Anthony Saleh
Chief Executive Officer miRecule
Anthony Saleh is the Co-founder and CEO of miRecule, Inc., a biotechnology company developing precision RNA therapeutics for cancer. A seasoned entrepreneur and scientist, he has extensive experience bridging discovery and commercialization. Prior to founding miRecule, Anthony was an Entrepreneur-in-Residence at BioHealth Innovation and held leadership roles at MIMETAS. His research background includes serving as a Scientist at the National Institutes of Health (NIH), where he led multi-disciplinary teams in cancer genomics and drug discovery, inventing a novel genomics-based platform and designing innovative therapeutic agents.
Seminars
Thursday 29th January 2026
Expanding RNAi Delivery to Muscle Tissue Through Antibody Oligonucleotide Conjugates
12:00 pm
- Antibody-siRNA conjugates enable muscle-selective uptake, treating myopathies with minimal off-target effects
- Enhanced endosomal escape increases cytoplasmic siRNA release, improving dystrophin restoration in Duchenne MD
- Modular platform allows rapid re-targeting, accelerating therapies for multiple rare muscle disorders
